"This is an extraordinary time for biotechnology. Science and technology are accelerating the cadence of innovation."Robert A. Bradway, Amgen CEO
Amgen helped launch the biotech industry more than 40 years ago and has reached millions of patients suffering from serious illness around the globe.
Many of the molecules in our pipeline represent potential first-in-class medicines for serious diseases.
Making a positive difference in the world is at the heart of what we do at Amgen — and it goes beyond making vital medicines.
We also help build a better world by focusing on environmental, social and governance (ESG) issues that matter most to our business and our stakeholders.